Randomized controlled clinical trial on prophylactic treatment of constipation with polyethylene glycol with electrolytes in the critically ill child.

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-509718-12-01

Acronym

PEM3350

Enrollment

233

Registered

2025-02-04

Start date

2025-05-09

Completion date

Unknown

Last updated

2025-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

constipation

Brief summary

- Efficacy assessment: the primary endpoint is stool output.

Detailed description

• Safety assessment: any adverse events, Assessment of stool consistency: the validated Bristol scale will be used.

Interventions

DRUGMovicol Pediátrico Sabor Neutro 6

DRUG9 g polvo para solución oral en sobre.

Eligibility

Sex/Gender

All

Age

0 Years to 17 Years

Design outcomes

Primary

Measure	Time frame
- Efficacy assessment: the primary endpoint is stool output.	—

Secondary

Measure	Time frame
• Safety assessment: any adverse events, Assessment of stool consistency: the validated Bristol scale will be used.	—

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026